Recruiting PHASE2 INTERVENTIONAL 1-arm NCT06904482

Co-Transplant of an Unmodified Haplo-Identical Graft With Cord Blood

Sponsor: Case Comprehensive Cancer Center

Conditions Acute Lymphocytic Leukemia Acute Myelogenous Leukemia Myelodysplastic Syndromes aGVHD

Interventions Haplo-Identical / Cord Blood Transplant

Updated 5 times since 2025 Last updated: Feb 25, 2026 Started: Aug 13, 2025 Primary completion: Feb 24, 2027 Completion: Feb 25, 2030

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Acute Lymphocytic Leukemia and Acute Myelogenous Leukemia and is currently actively recruiting participants. Case Comprehensive Cancer Center leads this study, which shows 5 recorded versions since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Feb 2026 — Present [monthly]

Recruiting PHASE2
Sep 2025 — Feb 2026 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting
Jul 2025 — Sep 2025 [monthly]

Not Yet Recruiting PHASE2
Jun 2025 — Jul 2025 [monthly]

Not Yet Recruiting PHASE2
May 2025 — Jun 2025 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Case Comprehensive Cancer Center

Data source: Case Comprehensive Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cleveland, United States